Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|October 26, 2020
Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, CanadaWei Fang Dai, Jaclyn Beca, Ruth Croxford, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|April 3, 2016
The association of adjuvant therapy with survival at the population level following pancreatic adenocarcinoma resectionDaniel J Kagedan, Ravish S Raju, Matthew E Dixon, et al.
Annals of Surgical Oncology|September 20, 2019
Economic Analysis of Adjuvant Chemoradiotherapy Compared with Chemotherapy in Resected Pancreas CancerNivethan Vela, Laura E Davis, Stephanie Y Cheng, et al.
The Oncologist|August 15, 2019
Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre ExperienceHamzeh Albaba, Tristan A Barnes, Zachary Veitch, et al.
The Journal of Community and Supportive Oncology|June 28, 2014
End-of-life home care utilization and costs in patients with advanced colorectal cancerNicole Mittmann, Ning Liu, Joan M Porter, et al.
Canadian Family Physician Medecin De Famille Canadien|October 15, 2016
Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative dataLi Jiang, Aisha Lofters, Rahim Moineddin, et al.
CMAJ Open|March 19, 2020
Health system costs for cancer medications and radiation treatment in Ontario for the 4 most common cancers: a retrospective cohort studyNicole Mittmann, Ning Liu, Stephanie Y Cheng, et al.
Lung Cancer (Amsterdam, Netherlands)|August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
Cancer Medicine|March 31, 2023
Cost-effectiveness of second-line ipilimumab for metastatic melanoma: A real-world population-based cohort study of resource utilizationBrandon Lu, Wei Fang Dai, Ruth Croxford, et al.
CMAJ Open|August 1, 2014
Utilization and costs of home care for patients with colorectal cancer: a population-based studyNicole Mittmann, Ning Liu, Joan Porter, et al.
Pageof 17